Abstract:Myocardial damage is the most serious pathological consequence of cardiovascular diseases and an important reason for their high mortality. In recent years, because of the high prevalence of systemic energy metabolism disorders (e.g., obesity, diabetes mellitus, and metabolic syndrome), complications of myocardial damage caused by these disorders have attracted widespread attention. Energy metabolism disorders are independent of traditional injury-related risk factors, such as ischemia, hypoxia, trauma, and infection. An imbalance of myocardial metabolic flexibility and myocardial energy depletion are usually the initial changes of myocardial injury caused by energy metabolism disorders, and abnormal morphology and functional destruction of the mitochondria are their important features. Specifically, mitochondria are the centers of energy metabolism, and recent evidence has shown that decreased mitochondrial function, caused by an imbalance in mitochondrial quality control, may play a key role in myocardial injury caused by energy metabolism disorders. Under chronic energy stress, mitochondria undergo pathological fission, while mitophagy, mitochondrial fusion, and biogenesis are inhibited, and mitochondrial protein balance and transfer are disturbed, resulting in the accumulation of nonfunctional and damaged mitochondria. Consequently, damaged mitochondria lead to myocardial energy depletion and the accumulation of large amounts of reactive oxygen species, further aggravating the imbalance in mitochondrial quality control and forming a vicious cycle. In addition, impaired mitochondria coordinate calcium homeostasis imbalance, and epigenetic alterations participate in the pathogenesis of myocardial damage. These pathological changes induce rapid progression of myocardial damage, eventually leading to heart failure or sudden cardiac death. To intervene more specifically in the myocardial damage caused by metabolic disorders, we need to understand the specific role of mitochondria in this context in detail. Accordingly, promising therapeutic strategies have been proposed. We also summarize the existing therapeutic strategies to provide a reference for clinical treatment and developing new therapies.

Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease

Role Of Mitophagy In Cardiovascular Disease

Dual Role of Mitophagy in Cardiovascular Diseases

Mitophagy in Cardiovascular Diseases: Molecular Mechanisms, Pathogenesis, and Treatment.

Mitophagy As a Mitochondrial Quality Control Mechanism in Myocardial Ischemic Stress: from Bench to Bedside

Emerging Role of Mitophagy in the Heart: Therapeutic Potentials to Modulate Mitophagy in Cardiac Diseases

Advances in Cardiotoxicity Induced by Altered Mitochondrial Dynamics and Mitophagy

Mitochondrial Dysfunction: A Roadmap for Understanding and Tackling Cardiovascular Aging.

Mitophagy for cardioprotection

Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease

Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation

Assessment of mitochondrial dysfunction and implications in cardiovascular disorders

The role of mitochondria in myocardial damage caused by energy metabolism disorders: From mechanisms to therapeutics

The mitophagy pathway and its implications in human diseases

Mitophagy, Mitochondrial Dynamics, and Homeostasis in Cardiovascular Aging

Mitophagy and its contribution to metabolic and aging associated disorders.

Mitophagy modulation for the treatment of cardiovascular diseases

Mitochondrial Dysfunction and Therapeutic Perspectives in Cardiovascular Diseases

Mitochondria in Pathological Cardiac Hypertrophy Research and Therapy

Mitochondrial Ca2+ Homeostasis: Emerging Roles and Clinical Significance in Cardiac Remodeling

The Role of Mitochondrial Fusion and Fission in the Process of Cardiac Oxidative Stress.